Pathogenic mechanisms of osteogenesis imperfecta, evidence for classification.


Journal

Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602

Informations de publication

Date de publication:
09 08 2023
Historique:
received: 07 06 2023
accepted: 31 07 2023
medline: 11 8 2023
pubmed: 10 8 2023
entrez: 9 8 2023
Statut: epublish

Résumé

Osteogenesis imperfecta (OI) is a connective tissue disorder affecting the skeleton and other organs, which has multiple genetic patterns, numerous causative genes, and complex pathogenic mechanisms. The previous classifications lack structure and scientific basis and have poor applicability. In this paper, we summarize and sort out the pathogenic mechanisms of OI, and analyze the molecular pathogenic mechanisms of OI from the perspectives of type I collagen defects(synthesis defects, processing defects, post-translational modification defects, folding and cross-linking defects), bone mineralization disorders, osteoblast differentiation and functional defects respectively, and also generalize several new untyped OI-causing genes and their pathogenic mechanisms, intending to provide the evidence of classification and a scientific basis for the precise diagnosis and treatment of OI.

Identifiants

pubmed: 37559063
doi: 10.1186/s13023-023-02849-5
pii: 10.1186/s13023-023-02849-5
pmc: PMC10411007
doi:

Substances chimiques

Collagen Type I 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

234

Informations de copyright

© 2023. Institut National de la Santé et de la Recherche Médicale (INSERM).

Références

Nat Rev Endocrinol. 2011 Jun 14;7(9):540-57
pubmed: 21670757
J Med Genet. 2001 Jul;38(7):443-9
pubmed: 11432962
J Bone Miner Res. 2021 Jun;36(6):1077-1087
pubmed: 33596325
Am J Hum Genet. 2020 Nov 5;107(5):989-999
pubmed: 33053334
Hum Mol Genet. 2010 Jan 15;19(2):223-34
pubmed: 19846465
Hum Mutat. 2013 Sep;34(9):1279-88
pubmed: 23712425
J Bone Miner Res. 2011 Dec;26(12):2798-803
pubmed: 21826736
Circ Res. 2014 Feb 14;114(4):706-16
pubmed: 24526676
Development. 2018 Oct 26;145(20):
pubmed: 30291163
Development. 2009 Jul;136(14):2355-61
pubmed: 19515693
Am J Med Genet A. 2021 Mar;185(3):743-752
pubmed: 33369194
Lancet. 2016 Apr 16;387(10028):1657-71
pubmed: 26542481
J Med Genet. 2013 Jan;50(1):21-4
pubmed: 23240094
Nat Commun. 2016 Jul 06;7:11920
pubmed: 27380894
J Neurochem. 2006 Feb;96(4):1090-100
pubmed: 16417584
Dis Model Mech. 2019 Jun 20;12(6):
pubmed: 31171565
Bone. 2022 Sep;162:116451
pubmed: 35654352
Hum Genomics. 2019 Jun 3;13(1):25
pubmed: 31159867
Hum Mutat. 2014 Nov;35(11):1330-41
pubmed: 25146735
Biochem Biophys Res Commun. 2019 Jan 29;509(1):235-240
pubmed: 30579604
J Clin Endocrinol Metab. 2017 Jun 1;102(6):2019-2028
pubmed: 28323974
Nat Rev Dis Primers. 2020 Jul 30;6(1):64
pubmed: 32732924
Hum Mutat. 2011 Jun;32(6):598-609
pubmed: 21344539
Am J Med Genet A. 2022 Jun;188(6):1815-1825
pubmed: 35278031
HGG Adv. 2021 Aug 20;2(4):100051
pubmed: 35047842
J Med Genet. 1979 Apr;16(2):101-16
pubmed: 458828
Am J Hum Genet. 2019 Oct 3;105(4):836-843
pubmed: 31564437
Matrix Biol. 2007 Oct;26(8):604-14
pubmed: 17662583
Int J Mol Med. 2018 Jan;41(1):381-390
pubmed: 29115376
Biochem Biophys Res Commun. 2002 Apr 26;293(1):470-7
pubmed: 12054625
J Biol Chem. 2020 Jul 24;295(30):10271-10280
pubmed: 32487748
Calcif Tissue Int. 2013 Oct;93(4):338-47
pubmed: 23508630
J Med Genet. 2018 Apr;55(4):278-284
pubmed: 29358272
J Bone Miner Res. 2020 Aug;35(8):1470-1480
pubmed: 32181939
Am J Med Genet A. 2019 Jun;179(6):908-914
pubmed: 30896082
J Orthop Surg Res. 2021 Jun 2;16(1):359
pubmed: 34078411
J Biol Chem. 2006 Apr 21;281(16):11177-85
pubmed: 16484215
Osteoporos Int. 2018 Jan;29(1):243-246
pubmed: 28916840
Cell. 2006 Oct 20;127(2):291-304
pubmed: 17055431
Am J Med Genet A. 2018 Nov;176(11):2419-2424
pubmed: 30246918
Dis Model Mech. 2022 May 1;15(5):
pubmed: 35575034
Biochem Biophys Res Commun. 2010 Jan 1;391(1):789-94
pubmed: 19945427
Genet Med. 2018 Apr;20(4):411-419
pubmed: 28817112
Nature. 2007 Jul 5;448(7149):78-82
pubmed: 17611541
Bone. 2022 Jul;160:116400
pubmed: 35367406
Hum Mutat. 2012 Nov;33(11):1589-98
pubmed: 22718341
Am J Hum Genet. 2011 Mar 11;88(3):362-71
pubmed: 21353196
Nat Genet. 2007 Mar;39(3):359-65
pubmed: 17277775
FASEB J. 1991 Apr;5(7):2052-60
pubmed: 2010058
Hum Genet. 2021 Aug;140(8):1121-1141
pubmed: 34169326
Nat Cell Biol. 2005 Feb;7(2):186-94
pubmed: 15665855

Auteurs

Hongjie Yu (H)

Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China.
Shandong Institute of Endocrine and Metabolic Diseases, Jinan, Shandong, 250021, China.
Shandong Engineering Research Center of Stem Cell and Gene Therapy for Endocrine and Metabolic Diseases, Jinan, Shandong, 250021, China.

Changrong Li (C)

Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China.
Shandong Institute of Endocrine and Metabolic Diseases, Jinan, Shandong, 250021, China.
Shandong Engineering Research Center of Stem Cell and Gene Therapy for Endocrine and Metabolic Diseases, Jinan, Shandong, 250021, China.

Huixiao Wu (H)

Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China.
Shandong Institute of Endocrine and Metabolic Diseases, Jinan, Shandong, 250021, China.
Shandong Engineering Research Center of Stem Cell and Gene Therapy for Endocrine and Metabolic Diseases, Jinan, Shandong, 250021, China.

Weibo Xia (W)

Department of Endocrinology, Key Laboratory of Endocrinology, Peking Union Medical College Hospital, National Commission of Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 100730.

Yanzhou Wang (Y)

Department of Pediatric Orthopedics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China.

Jiajun Zhao (J)

Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China.
Shandong Institute of Endocrine and Metabolic Diseases, Jinan, Shandong, 250021, China.
Shandong Engineering Research Center of Stem Cell and Gene Therapy for Endocrine and Metabolic Diseases, Jinan, Shandong, 250021, China.

Chao Xu (C)

Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China. doctorxuchao@163.com.
Shandong Institute of Endocrine and Metabolic Diseases, Jinan, Shandong, 250021, China. doctorxuchao@163.com.
Shandong Engineering Research Center of Stem Cell and Gene Therapy for Endocrine and Metabolic Diseases, Jinan, Shandong, 250021, China. doctorxuchao@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH